Charles River Laboratories (CRL)
Pretax margin
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Earnings before tax but after interest (EBT) | US$ in thousands | 90,026 | 575,538 | 616,605 | 472,855 | 446,112 |
| Revenue | US$ in thousands | 4,120,490 | 4,082,940 | 4,098,090 | 3,457,220 | 2,939,570 |
| Pretax margin | 2.18% | 14.10% | 15.05% | 13.68% | 15.18% |
December 31, 2024 calculation
Pretax margin = EBT ÷ Revenue
= $90,026K ÷ $4,120,490K
= 2.18%
The pretax margin of Charles River Laboratories has shown fluctuations over the past five years. In December 2020, the pretax margin stood at 15.18%, indicating that for every dollar of revenue generated, the company retained $0.1518 before accounting for taxes. Over the following years, there were slight decreases in the pretax margin, with figures of 13.68% in December 2021 and 14.10% in December 2023. The margin saw a significant drop to 2.18% by December 2024, suggesting a notable decline in profitability before taxes. It is important for stakeholders to further investigate the reasons behind this drastic decrease to assess the company's financial performance and sustainability.
Peer comparison
Dec 31, 2024